Repurposing Penfluridol to combat mycobacteria via bioenergetic collapse
Microbiology Spectrum · 2026
DOI: 10.1128/spectrum.01919-26 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, 2026. Verfasst von Yunbing Li und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. Hauptthemen laut MEDLINE: Antitubercular Agents, Mycobacterium tuberculosis, Drug Repositioning, Penfluridol. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Natural Science Foundation of Zhejiang Province.
Abstract (Originalsprache)
Drug-resistant Mycobacterium tuberculosis (Mtb) infections constitute a persistent and severe public health crisis worldwide. Standard anti-tuberculosis (anti-TB) therapies often fail to eradicate resistant strains, resulting in poor clinical outcomes and underscoring the demand for new treatment options. Drug repurposing offers a practical and time-efficient approach to accelerate the development of new anti-mycobacterial regimens. In this work, we evaluated the antimycobacterial potency of penfluridol (PL), a Food and Drug Administration (FDA)-approved antipsychotic drug, and explored its functional mechanism against mycobacteria. Our experimental data revealed that PL compromises mycobacterial membrane integrity and depletes the proton motive force (PMF), leading to disrupted energy metabolism and mycobacterial growth inhibition. PMF depletion disables energy-reliant efflux systems, facilitates intracellular PL accumulation, and further deteriorates membrane damage, creating a sustained bactericidal effect. Notably, continuous PL exposure rarely induces stable drug resistance. These observations suggest that PL can be repurposed for treating drug-resistant TB and confirm that targeting bacterial bioenergetics is an effective strategy to overcome clinical antimicrobial resistance. IMPORTANCE Tuberculosis (TB) remains a major threat to global public health, and the widespread emergence of drug-resistant strains has substantially compromised the efficacy of existing anti-TB regimens. The scarcity of approved anti-TB drugs, combined with lengthy treatment regimens and frequent therapeutic failure, further exacerbates the global TB crisis, highlighting an urgent need for safe and effective alternative therapies. Drug repurposing serves as a time-saving and reliable strategy to accelerate anti-TB drug development. This study explores the antimycobacterial efficacy and unique working mechanism of the clinically approved agent penfluridol (PL). Our findings identify a feasible candidate for treating drug-resistant TB and provide a valuable bioenergetic-targeting strategy to combat bacterial antimicrobial resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Emergency Medicine, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- Department of Medical Microbiology, Experimental Center, Suzhou Medical College of Soochow University, Suzhou, China.
- Key Laboratory of Chemical Biology and Molecular Engineering of Ministry of Education, Biomedical and Health Laboratory in Shanxi Province, Institutes of Biomedical Sciences, School of Life Science, Shanxi University, T…
- Biomedicine and Health Laboratory in Shanxi Province, Taiyuan, China.
- Department of Pathology, Children's Hospital, Zhejiang University School of Medicine, National Children's Regional Medical Center, National Clinical Research Center for Child Health, Hangzhou, China.
- Department of Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, China.
ORCID-Profile: Zhiqiang Yang, Chen Xu, Ning Dong
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Natural Science Foundation of Zhejiang Province
- Natural Science Foundation of Jiangsu Province
- Open Research Project of Biomedicine and Health Laboratory in Shanxi Province
- The first batch of key core technology research of "Uncovering the top leadership" project of Taiyuan bureau of science and technology
- The first batch of key core technology research of “Uncovering the top leadership” project of Taiyuan bureau of science and technology
Zitieren
APA
Li, Y., Li, X., Zhang, G., Li, C., Yin, C., Li, Y., Jiang, J., Yang, Y., Yang, Z., Liu, Y., Zeng, X., You, J., Liu, Y., Li, A., Jiang, C., Xu, C., & Dong, N. (2026). Repurposing Penfluridol to combat mycobacteria via bioenergetic collapse. Microbiology Spectrum. https://doi.org/10.1128/spectrum.01919-26
Vancouver
Li Y, Li X, Zhang G, Li C, Yin C, Li Y, et al. Repurposing Penfluridol to combat mycobacteria via bioenergetic collapse. Microbiology Spectrum. 2026. doi:10.1128/spectrum.01919-26
BibTeX
@article{Li2026,
author = {Li, Yunbing and Li, Xiaofan and Zhang, Guangfen and Li, Chunli and Yin, Changting and Li, Yuanyuan and Jiang, Jiani and Yang, Yi and Yang, Zhiqiang and Liu, Yinli and Zeng, Xiangkun and You, Jiayi and Liu, Yi and Li, Ahui and Jiang, Chang and Xu, Chen and Dong, Ning},
title = {Repurposing Penfluridol to combat mycobacteria via bioenergetic collapse},
journal = {Microbiology Spectrum},
year = {2026},
doi = {10.1128/spectrum.01919-26}
}
EUVIMED